Intellectual Property Providing access to medicines at affordable prices while maintaining incentives for the originators to invest into significant innovations is a balance that’s hard to find. Product hopping is a strategy for originators to minimise the erosion of their sales that has caught the attention of regulators and courts.
Intellectual Property Providing access to medicines at affordable prices while maintaining incentives for the originators to invest into significant innovations is a balance that’s hard to find. Product hopping is a strategy for originators to minimise the erosion of their sales that has caught the attention of regulators and courts.
Immatics Biotechnologies has landed a potential US$1.1bn deal with GlaxoSmithKline (GSK) to find novel cancer targets on solid tumours and to direct TCR-T cell therapies against them. European Biotechnology spoke with Dr Harpreet Singh, CEO of Immatics Biotechnologies.
For years, French Carbios SAS has worked to set up a process that effectively depolymerizes PET, one of the most common plastics. Now its process has been published.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2020-04-15_um_08.33.32.png437707Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-04-15 08:07:112020-04-15 08:07:11Carbios SAS publishes PET recycling technology
https://european-biotechnology.com/wp-content/uploads/2024/04/Mobidiag_Tecan.jpg370720Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-04-14 09:29:512020-04-14 09:29:51Mobidiag’s COVID-19 test okayed for emergency use
https://european-biotechnology.com/wp-content/uploads/2024/04/2020_04_13_EBM_800px-Pseudomonas_CDC_sw_Kopie.jpg433769Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-04-13 00:45:592024-04-02 16:20:33Is AMR the next, but hidden, crisis?
Every year, it’s the same: in January, investors are scratching their heads, searching to find investment ideas that could ensure the greatest return/performance. Given the current valuation, can 2020 deliver windfall surprises for European names?
Product hopping Boon or Bane?
OpinionIntellectual Property Providing access to medicines at affordable prices while maintaining incentives for the originators to invest into significant innovations is a balance that’s hard to find. Product hopping is a strategy for originators to minimise the erosion of their sales that has caught the attention of regulators and courts.
Product hopping – Boon or Bane?
OpinionIntellectual Property Providing access to medicines at affordable prices while maintaining incentives for the originators to invest into significant innovations is a balance that’s hard to find. Product hopping is a strategy for originators to minimise the erosion of their sales that has caught the attention of regulators and courts.
COVID 19: Halix ready for vaccine production
Latest NewsDutch Halix BV will manufacture a ChAdOx1 nCoV-19 vaccine, developed at the University of Oxford .
Cellectis appoints new CMO
AppointmentsCarrie Brownstein has started as the new Chief Medical Officer at Cellectis, a French biopharmaceutical company.
Expansion through partnerships
OpinionImmatics Biotechnologies has landed a potential US$1.1bn deal with GlaxoSmithKline (GSK) to find novel cancer targets on solid tumours and to direct TCR-T cell therapies against them. European Biotechnology spoke with Dr Harpreet Singh, CEO of Immatics Biotechnologies.
Carbios SAS publishes PET recycling technology
Latest NewsFor years, French Carbios SAS has worked to set up a process that effectively depolymerizes PET, one of the most common plastics. Now its process has been published.
Mobidiag’s COVID-19 test okayed for emergency use
Latest NewsMolecular diagnostics specialist Mobidiag Ltd has got emergency approval for its Amplidiag® COVID-19 molecular diagnostic test in Finland.
Is AMR the next, but hidden, crisis?
BackgroundWith the coronavirus pandemic mounting, experts are warning of AMR as being the next, hidden crisis.
Researchers reconstruct SARS-CoV-2 evolution
Latest NewsBritish researchers have tabled a phylogenetic tree showing different subtypes of SARS-CoV-2 developed in Asia, Europe and the US.
European assets ahead despite virus panic
OpinionEvery year, it’s the same: in January, investors are scratching their heads, searching to find investment ideas that could ensure the greatest return/performance. Given the current valuation, can 2020 deliver windfall surprises for European names?